Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Return on Sales (2023 - 2025)

Immunocore Holdings' Return on Sales history spans 3 years, with the latest figure at 0.29% for Q4 2025.

  • For Q4 2025, Return on Sales fell 1.0% year-over-year to 0.29%; the TTM value through Dec 2025 reached 0.09%, up 8.0%, while the annual FY2025 figure was 0.09%, 8.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.29% at Immunocore Holdings, down from 0.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.11% in Q3 2024 and bottomed at 0.36% in Q1 2023.
  • The 3-year median for Return on Sales is 0.22% (2023), against an average of 0.16%.
  • The largest YoY upside for Return on Sales was 40bps in 2025 against a maximum downside of -11bps in 2025.
  • A 3-year view of Return on Sales shows it stood at 0.28% in 2023, then decreased by 0bps to 0.28% in 2024, then fell by -2bps to 0.29% in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Return on Sales are 0.29% (Q4 2025), 0.0% (Q3 2025), and 0.11% (Q2 2025).